The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study

The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study

Abstract Background Chemotherapies are still widely used in advanced breast cancer, specifically in patients with HER2-negative disease. This non-interventional real-world study assessed the utilization of nab-paclitaxel in a broad patient population with advanced breast cancer. Methods SERAPHINA (N...

Full description

Saved in:
Bibliographic Details
Main Authors: Andreas Schneeweiss, Peter A. Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Hans Tesch, Tanja N. Fehm, Tjoung-Won Park-Simon, Lothar Häberle, Sabrina Uhrig, Oliver Tome, Thomas Spall, Anna-Katharin Theuser, Matthias Ruebner, Erik Belleville, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Journal of Cancer Research and Clinical Oncology
Subjects:
Advanced breast cancer
Nab-paclitaxel
Chemotherapy
Real-world
Non-interventional study
Online Access:https://doi.org/10.1007/s00432-025-06246-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s00432-025-06246-2

Similar Items